The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells

References

• Van Itallie CM, Anderson JM. Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol [Internet] [cited 2014 Sep 30]; Available from: "http://www.sciencedirect.comsciencearticlepiiS1084952114002511"; PMID: 25171873
   PubMed Web of Science ®Google Scholar
• Matter K, Aijaz S, Tsapara A, Balda MS. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005; 17:453-8; PMID:16098725; http://dx.doi.org/10.1016/j.ceb.2005.08.003
   PubMed Web of Science ®Google Scholar
• Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27:6939-57; PMID: 19029936; http://dx.doi.org/10.1038/onc.2008.345
   PubMed Web of Science ®Google Scholar
• Gassama-Diagne A, Yu W, ter Beest M, Martin-Belmonte F, Kierbel A, Engel J, Mostov K. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol 2006; 8:963-70; PMID:16921364; http://dx.doi.org/10.1038/ncb1461
   PubMed Web of Science ®Google Scholar
• Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, Mostov K. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 2007; 128:383-97; PMID:17254974; http://dx.doi.org/10.1016/j.cell.2006.11.051
   PubMed Web of Science ®Google Scholar
• Guillot C, Lecuit T. Mechanics of epithelial tissue homeostasis and horphogenesis. Science 2013; 340:1185-9; PMID:23744939; http://dx.doi.org/10.1126/science.1235249
   PubMed Web of Science ®Google Scholar
• Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 2010; 20:142-9; PMID:20061152; http://dx.doi.org/10.1016/j.tcb.2009.12.002
   PubMed Web of Science ®Google Scholar
• Camilleri-Broet S, Cremer I, Marmey B, Comperat E, Viguie F, Audouin J, Rio MC, Fridman WH, Sautes-Fridman C, Regnier CH. TRAF4 overexpression is a common characteristic of human carcinomas. Oncogene 2007; 26:142-7; PMID:16799635; http://dx.doi.org/10.1038/sj.onc.1209762
   PubMed Web of Science ®Google Scholar
• Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 1995; 270:25715-21; PMID:7592751; http://dx.doi.org/10.1074/jbc.270.43.25715
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101:9309-14; http://dx.doi.org/10.1073/pnas.0401994101
   PubMed Web of Science ®Google Scholar
• Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 1995; 28:367-76; PMID:7490069; http://dx.doi.org/10.1006/geno.1995.1163
   PubMedGoogle Scholar
• Zhang L, Zhou F, GarcíadeVinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol Cell 2013; 51:559-72; PMID:23973329; http://dx.doi.org/10.1016/j.molcel.2013.07.014
   PubMed Web of Science ®Google Scholar
• Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001; 20:6482-91; PMID:11607847; http://dx.doi.org/10.1038/sj.onc.1204788
   PubMed Web of Science ®Google Scholar
• Zotti T, Vito P, Stilo R. The seventh ring: Exploring TRAF7 functions. J Cell Physiol 2012; 227:1280-4; PMID:22105767; http://dx.doi.org/10.1002/jcp.24011
   PubMedGoogle Scholar
• Rousseau A, Rio M-C, Alpy F. TRAF4, at the crossroad between morphogenesis and cancer. Cancers 2011; 3:2734-49; PMID:24212830; http://dx.doi.org/10.3390/cancers3022734
   PubMedGoogle Scholar
• Kedinger V, Alpy F, Baguet A, Polette M, Stoll I, Chenard MP, Tomasetto C, Rio MC. Tumor necrosis factor receptor-associated factor 4 is a dynamic tight junction-related shuttle protein involved in epithelium homeostasis. PLoS ONE 2008; 3:e3518; PMID:18953416; http://dx.doi.org/10.1371/journal.pone.0003518
   PubMed Web of Science ®Google Scholar
• Rousseau A, McEwen AG, Poussin-Courmontagne P, Rognan D, Nominé Y, Rio M-C, Tomasetto C, Alpy F. TRAF4 Is a novel phosphoinositide-binding protein modulating tight junctions and favoring cell migration. PLoS Biol 2013; 11:e1001726; PMID:24311986; http://dx.doi.org/10.1371/journal.pbio.1001726
   PubMed Web of Science ®Google Scholar
• Glauner H, Siegmund D, Motejadded H, Scheurich P, Henkler F, Janssen O, Wajant H. Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4). Eur J Biochem FEBS 2002; 269:4819-29; http://dx.doi.org/10.1046/j.1432-1033.2002.03180.x
   PubMedGoogle Scholar
• Régnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 1995; 270:25715-21; http://dx.doi.org/10.1074/jbc.270.43.25715
   PubMed Web of Science ®Google Scholar
• Yi P, Xia W, Wu R-C, Lonard DM, Hung M-C, O’Malley BW. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization. Genes Dev 2013; 27:274-87; PMID: 23388826; http://dx.doi.org/10.1101/gad.203760.112
   PubMedGoogle Scholar
• Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999; 398:533-8; PMID:10206649; http://dx.doi.org/10.1038/19110
   PubMed Web of Science ®Google Scholar
• Yin Q, Lin SC, Lamothe B, Lu M, Lo YC, Hura G, Zheng L, Rich RL, Campos AD, Myszka DG, et al. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009; 16:658-66; PMID:19465916; http://dx.doi.org/10.1038/nsmb.1605
   PubMed Web of Science ®Google Scholar
• Wu H, Feng W, Chen J, Chan LN, Huang S, Zhang M. PDZ domains of Par-3 as potential phosphoinositide signaling integrators. Mol Cell 2007; 28:886-98; PMID:18082612; http://dx.doi.org/10.1016/j.molcel.2007.10.028
   PubMedGoogle Scholar
• Meerschaert K, Tun MP, Remue E, De Ganck A, Boucherie C, Vanloo B, Degeest G, Vandekerckhove J, Zimmermann P, Bhardwaj N, et al. The PDZ2 domain of zonula occludens-1 and -2 is a phosphoinositide binding domain. Cell Mol Life Sci CMLS 2009; 66:3951-66; http://dx.doi.org/10.1007/s00018-009-0156-6
   PubMed Web of Science ®Google Scholar
• Ozdamar B, Bose R, Barrios-Rodiles M, Wang H-R, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005; 307:1603-9; PMID:15761148; http://dx.doi.org/10.1126/science.1105718
   PubMed Web of Science ®Google Scholar
• Li S, Lu K, Wang J, An L, Yang G, Chen H, Cui Y, Yin X, Xie P, Xing G, et al. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol Cell Biochem 2010; 338:11-7; PMID:19937093; http://dx.doi.org/10.1007/s11010-009-0315-y
   PubMedGoogle Scholar
• Wang X, Jin C, Tang Y, Tang L-Y, Zhang YE. Ubiquitination of tumor necrosis factor receptor-associated Factor 4 (TRAF4) by smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. J Biol Chem 2013; 288:21784-92; PMID: 23760265; http://dx.doi.org/10.1074/jbc.M113.472704
   PubMed Web of Science ®Google Scholar
• Rozan LM, El-Deiry WS. Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target. Cancer Biol Ther 2006; 5:1228-35; PMID: 16969126; http://dx.doi.org/10.4161/cbt.5.9.3295
   PubMed Web of Science ®Google Scholar
• Sax JK, El-Deiry WS. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem 2003; 278:36435-44; PMID:12788948; http://dx.doi.org/10.1074/jbc.M303191200
   PubMedGoogle Scholar
• Zapata JM, Martinez-Garcia V, Lefebvre S. Phylogeny of the TRAFMATH domain. Adv Exp Med Biol 2007; 597:1-24; PMID:17633013; http://dx.doi.org/10.1007/978-0-387-70630-6_1
   PubMed Web of Science ®Google Scholar
• Mathew SJ, Rembold M, Leptin M. Role for Traf4 in polarizing adherens junctions as a prerequisite for efficient cell shape changes. Mol Cell Biol 2011; 31:4978-93; PMID:21986496; http://dx.doi.org/10.1128/MCB.05542-11
   PubMed Web of Science ®Google Scholar
• Xu L-G, Li L-Y, Shu H-B. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J Biol Chem 2004; 279:17278-82; PMID:15001576; http://dx.doi.org/10.1074/jbc.C400063200
   PubMedGoogle Scholar
• Napetschnig J, Wu H. Molecular basis of NF-κB signaling. Annu Rev Biophys 2013; 42:443-68; PMID:23495970; http://dx.doi.org/10.1146/annurev-biophys-083012-130338
   PubMed Web of Science ®Google Scholar
• Ye H, Park YC, Kreishman M, Kieff E, Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999; 4:321-30; PMID:10518213; http://dx.doi.org/10.1016/S1097-2765(00)80334-2
   PubMed Web of Science ®Google Scholar
• Delano W. The PyMOL molecular graphics system [Internet]. San Carlos, USA: Delano Sientific; 2002. Available from: "http://www.pymol.org"
   Google Scholar